对癌症患者进行心身医学小组计划的影响:一项回顾性队列研究
Severin Schricker1,2, Felix Breßmer1, Mark Dominik Alscher1,2,3
1Robert-Bosch-Hospital, Stuttgart, Germany.
Integrative cancer therapies
|October 17, 2025
概括
心身医学 (MBM) 组干预措施显著改善了癌症患者的生活质量. 这种方法有效地减少了疲劳,压力,焦虑和抑郁等症状,提高了治疗期间的整体幸福感.
科学领域:
- 综合性瘤学 综合性瘤学
- 心灵与身体的医学
- 精神瘤学 精神瘤学
背景情况:
- 癌症治疗可以提高生存率,但往往会降低患者的生活质量.
- 常见的治疗副作用包括疲劳,疼痛,睡眠障碍,抑郁和焦虑.
- 正在探索心身医学 (MBM) 的干预措施,以减轻这些不良影响.
研究的目的:
- 评估结构化的MBM小组干预对癌症患者症状领域的影响.
- 为了评估疲劳,压力,睡眠质量,整体体质量,焦虑和抑郁症的改善.
主要方法:
- 一个为期11周的MBM小组计划,结合了精神瘤学,生活方式医学和整合疗法.
- 参与者 (n=113) 通过使用标准化问卷进行了干预前后评估.
- 这些措施包括MFI,PSS,PSQI,FACT-G和HADS来评估症状变化.
主要成果:
- 在所有结果措施中观察到显著的改善 (P < .001),效果大小为中大.
- 疲劳,压力,生活质量,焦虑,抑郁和睡眠质量都显著改善.
- 较差的起始睡眠质量预测了抑郁症和睡眠质量的更大改善.
结论:
- MBM 团体计划为瘤治疗提供了宝贵的补充,提高了患者的生活质量.
- 这些干预措施涉及癌症治疗的身体和心理方面.
- 将MBM整合到标准的癌症治疗方案中,促进了整体的护理方法.
相关概念视频
Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K

